Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Invus
Biotech
Septerna launches with $100M and GPCR pioneer co-founder
Septerna snagged $100 million and GPCR expert Robert Lefkowitz, to help steer the biotech toward the clinic in 2023.
Kyle LaHucik
Jan 27, 2022 7:00am
Korro Bio rings in new year with $116M for OPERA RNA editing
Jan 5, 2022 7:30am
Asher Bio snags $108M series B for three immunotherapy programs
Sep 1, 2021 7:00am
Abata launches with $95M series A for MS cell therapy
Jun 23, 2021 7:00am
ViaCyte scores $45M for type 1 diabetes drugs in midstage trials
Jun 9, 2021 2:47pm
Evox Therapeutics reels in $95M to propel exosome-based pipeline
Feb 18, 2021 9:35am
